Cancer Research Cancer Epigenetics  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 1902-1908, April 15, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Timar, J.
Right arrow Articles by Honn, K. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Timar, J.
Right arrow Articles by Honn, K. V.

Autocrine Motility Factor Signals Integrin-mediated Metastatic Melanoma Cell Adhesion and Invasion1

Jozsef Timar2, Mohit Trikha2, Karoly Szekeres, Rajesh Bazaz, Jozsef Tovari, Steve Silletti, Avraham Raz and Kenneth V. Honn3

First Institute of Pathology and Experimental Cancer Research, Semmelweis University of Medicine, Budapest, H-1085, Hungary [J. Ti., J. To.]; Departments of Radiation Oncology [M. T., K. S., R. B., K. V. H.] and Pathology and Chemistry [K. V. H.], Wayne State University, Detroit, Michigan 48202; and Metastasis Research Program, Karmanos Cancer Institute, Detroit, Michigan 48201 [S. S., A. R.]

The binding of autocrine motility factor (AMF) to its cell surface receptor, gp78, stimulates tumor cell motility. In this report, we provide evidence that stimulation of gp78 by either AMF or a monoclonal anti-body to gp78 (3F3A) increases adhesion and spreading of metastatic murine melanoma (B16a) cells on fibronectin. This gp78-regulated increase is mediated by up-regulation of surface {alpha}IIbß3 and {alpha}5ß1 integrin receptors. In addition, AMF treatment of B16a cells increased translocation of {alpha}IIbß3 and {alpha}5ß1 from the cytoplasm to the cell surface. However, {alpha}IIbß3 and {alpha}5ß1 demonstrate separate and unique staining patterns at the surface of B16a cells in response to stimulation of gp78. Furthermore, stimulation of B16a cells with AMF increased their invasion through Matrigel. This stimulated invasion was inhibited by antibodies to {alpha}IIbß3 but not by antibodies to {alpha}5ß1. The increased integrin surface expression and function in response to AMF was blocked by N-benzyl-N-hydroxy-5-phenylpentanamide, an inhibitor of 12-lipoxygenase, and calphostin C, an inhibitor of protein kinase C. The results demonstrate that AMF stimulates integrin-mediated B16a cell adhesion, spreading, and invasion, and these events are regulated by a signaling pathway involving 12-lipoxygenase and protein kinase C.

1 This work was supported by NIH Department of Health and Human Services Grants CA-47115-04 (to K. V. H.), CA-29997-08 (to K. V. H.), TW-285-02 (to K. V. H. and J. T.), and CA-51714 (to A. R.); The Paul Zuckermann Support for Cancer Research (to A. R.); NATO LG92311 (K. V. H. and J. T.); and the Hungarian National Science Fund, T6336 (to J. T.).

2 The first two authors contributed equally to this work.

3 To whom requests for reprints should be addressed, at Department of Pathology and Chemistry, 431 Chemistry. Wayne State University, Detroit, MI 48202. Phone: (313) 577-1018; Fax: (313) 577-0798.

Received 9/13/95. Accepted 2/15/96.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Araki, T. Shimura, T. Yajima, S. Tsutsumi, H. Suzuki, K. Okada, T. Kobayashi, A. Raz, and H. Kuwano
Phosphoglucose Isomerase/Autocrine Motility Factor Promotes Melanoma Cell Migration through ERK Activation Dependent on Autocrine Production of Interleukin-8
J. Biol. Chem., November 20, 2009; 284(47): 32305 - 32311.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Lagana, J. G. Goetz, N. Y, Y. Altschuler, and I. R. Nabi
pH-specific sequestration of phosphoglucose isomerase/autocrine motility factor by fibronectin and heparan sulphate
J. Cell Sci., September 15, 2005; 118(18): 4175 - 4185.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Tsutsumi, T. Yanagawa, T. Shimura, H. Kuwano, and A. Raz
Autocrine Motility Factor Signaling Enhances Pancreatic Cancer Metastasis
Clin. Cancer Res., November 15, 2004; 10(22): 7775 - 7784.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Podar, Y.-T. Tai, B. K. Lin, R. P. Narsimhan, M. Sattler, T. Kijima, R. Salgia, D. Gupta, D. Chauhan, and K. C. Anderson
Vascular Endothelial Growth Factor-induced Migration of Multiple Myeloma Cells Is Associated with beta 1 Integrin- and Phosphatidylinositol 3-Kinase-dependent PKCalpha Activation
J. Biol. Chem., March 1, 2002; 277(10): 7875 - 7881.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Le, N Benlimame, A Lagana, A Raz, and I. Nabi
Clathrin-mediated endocytosis and recycling of autocrine motility factor receptor to fibronectin fibrils is a limiting factor for NIH-3T3 cell motility
J. Cell Sci., January 9, 2000; 113(18): 3227 - 3240.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
I. Nabi
The polarization of the motile cell
J. Cell Sci., January 6, 1999; 112(12): 1803 - 1811.
[Abstract] [PDF]


Home page
J. Histochem. Cytochem.Home page
I. R. Nabi, G. Guay, and D. Simard
AMF-R Tubules Concentrate in a Pericentriolar Microtubule Domain After MSV Transformation of Epithelial MDCK Cells
J. Histochem. Cytochem., October 1, 1997; 45(10): 1351 - 1364.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.